Abstract
Purpose
To evaluate the effect of controlled ovarian stimulation (COH) with gonadotropins on the serum levels of autoantibodies in the women who underwent in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles and to compare basal levels of these autoantibodies between groups according to history of COH.
Methods
This prospective cohort study was performed from October 2014 to March 2016 in the Royan Institute. The volunteered infertile women with regard to the inclusion criteria, who underwent IVF/ICSI cycles, were recruited. The COH was performed according to standard long GnRH agonist protocol. The mean levels of the autoantibodies including anti-nuclear, anti-smooth muscle, anti-ovarian, anti-mitochondrial, anti β2-glycoprotein I, anti-parietal cell and anti-follicle-stimulating hormone antibodies were measured at three time points: on the 3–5 days of the menstrual cycle, 1 week after starting of COH and the ovum pick-up (OPU) day.
Results
Of all participants (n = 189), 73 women had history of COH (group B) and 116 women did not have such history (group A). The analysis indicated that the autoantibodies changes during COH were similar in both groups. COH has no significant impact on the level of autoantibodies during the stimulation cycle. Multiple logistic regression analysis showed that the serum levels of anti-smooth muscle antibody on OPU day was the positive predictive factors for live birth following ART cycles in the studied population.
Conclusion
No significant effect of COH on the studied autoantibodies by the time of OPU was found but further studies are required to interpret these results.
Similar content being viewed by others
References
Serna J, Garcia-Velasco JA (2005) Effect of repeated assisted reproduction techniques on the ovarian response. Curr Opin Obstet Gynecol 17(3):233–236 (Epub 2005/05/05)
Luk J, Arici A (2010) Does the ovarian reserve decrease from repeated ovulation stimulations? Curr Opin Obstet Gynecol 22(3):177–182
Kolibianakis E, Osmanagaoglu K, Camus M, Tournaye H, Van Steirteghem A, Devroey P (2002) Effect of repeated assisted reproductive technology cycles on ovarian response. Fertil Steril 77(5):967–970 (Epub 2002/05/16)
Caligara C, Navarro J, Vargas G, Simon C, Pellicer A, Remohi J (2001) The effect of repeated controlled ovarian stimulation in donors. Hum Reprod 16(11):2320–2323 (Epub 2001/10/27)
Hoveyda F, Engmann L, Steele J, Lopez Bernal A, Barlow DH (2002) Ovarian response in three consecutive in vitro fertilization cycles. Fertil Steril 77(4):706–710 (Epub 2002/04/09)
Magarey GM, Rodger JC, Buist JM, Mate KE (2003) Effects of repeated superovulation and surgical oocyte collection on ovarian response and natural breeding ability of the tammar wallaby (Macropus eugenii). Reproduction 125(5):701–707 (Epub 2003/04/26)
De Castro MP, Cortell C, Moce E, Marco-Jimenez F, Joly T, Vicente JS (2009) Effect of recombinant gonadotropins on embryo quality in superovulated rabbit does and immune response after repeated treatments. Theriogenology 72(5):655–662
Diamond MP, Polan ML, Blanchette M, Mazure CM, DeCherney AH, Lunenfeld B (1992) Comparison of ovarian response in the same women with the same or different lots of human menopausal gonadotropin. Gynecol Endocrinol 6(2):135–139 (Epub 1992/06/01)
Meyer WR, Lavy G, DeCherney AH, Visintin I, Economy K, Luborsky JL (1990) Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol 75(5):795–799 (Epub 1990/05/01)
Haller K, Sarapik A, Talja I, Salumets A, Uibo R (2006) Controlled ovarian hyperstimulation changes the prevalence of serum autoantibodies in in vitro fertilization patients. Am J Reprod Immunol 56(5–6):364–370 (Epub 2006/11/02)
Haller K, Salumets A, Uibo R (2008) Anti-FSH antibodies associate with poor outcome of ovarian stimulation in IVF. Reprod Biomed Online 16(3):350–355 (Epub 2008/03/15)
Luborsky J, Thiruppathi P, Rivnay B, Roussev R, Coulam C, Radwanska E (2002) Evidence for different aetiologies of low estradiol response to FSH: age-related accelerated luteinization of follicles or presence of ovarian autoantibodies. Hum Reprod 17(10):2641–2649
Morte C, Celma C, De Geyter C, Urbancsek J, Coroleu Lletget B, Cometti B (2017) Assessment of the immunogenicity of gonadotrophins during controlled ovarian stimulation. Am J Reprod Immunol 78:e12675. https://doi.org/10.1111/aji.12675
Cooper TG, Noonan E, Von Eckardstein S et al (2010) World Health Organization reference values for human semen characteristics. Hum Reprod Update 16(3):231–245
Ramezanali F, Ashrafi M, Hemat M, Arabipoor A, Jalali S, Moini A (2016) Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-mullerian hormone. Reprod Biomed Online 32(5):503–512 (Epub 2016/03/13)
Gelbaya TA, Potdar N, Jeve YB, Nardo LG (2014) Definition and epidemiology of unexplained infertility. Obstet Gynecol Surv 69(2):109–115
Ashrafi M, Hemat M, Arabipoor A, Salman Yazdi R, Bahman-Abadi A, Cheraghi R (2017) Predictive values of anti-mullerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes. J Obstet Gynaecol 37(1):82–88 (Epub 2016/12/16)
Haller K, Sikut A, Karro H, Uibo R, Salumets A (2008) Circulating anti-follicle-stimulating hormone immunoglobulin A in women: a sperm-prone reaction of mucosal tolerance? Fertil Steril 90(4):1253–1255 (Epub 2007/12/25)
Fisch B, Rikover Y, Shohat L et al (1991) The relationship between in vitro fertilization and naturally occurring antibodies: evidence for increased production of antiphospholipid autoantibodies. Fertil Steril 56(4):718–724 (Epub 1991/10/01)
Monnier-Barbarino P, Jouan C, Dubois M, Gobert B, Faure G, Bene MC (2003) Anti-ovarian antibodies and in vitro fertilization: cause or consequence? Gynecol Obstet Fertil 31(9):770–773 (epub 2003/09/23; anticorps anti-ovaires et fecondation in vitro: cause ou consequence?)
Ghirardello A, Gizzo S, Noventa M et al (2015) Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity. J Assist Reprod Genet 32(12):1765–1772
Kadioglu N, Guler B, Ozler S, Kilic S, Cicek MN, Batioglu AS (2016) Ovulation induction is a more effective stimulant on antiovarian antibody production than in vitro fertilization. Adv Ther 33(8):1408–1416
Cutolo M, Sulli A, Capellino S et al (2004) Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 13(9):635–638 (Epub 2004/10/16)
Gizzo S, Noventa M, Quaranta M et al (2016) The potential role of GnRH agonists and antagonists in inducing thyroid physiopathological changes during IVF. Reprod Sci 23(4):515–523
Haller K, Mathieu C, Rull K, Matt K, Bene MC, Uibo R (2005) IgG, IgA and IgM antibodies against FSH: serological markers of pathogenic autoimmunity or of normal immunoregulation? Am J Reprod Immunol 54(5):262–269 (Epub 2005/10/11)
Reimand K, Talja I, Metskula K, Kadastik U, Matt K, Uibo R (2001) Autoantibody studies of female patients with reproductive failure. J Reprod Immunol 51(2):167–176 (Epub 2001/09/07)
Haller K, Salumets A, Grigorova M et al (2007) Putative predictors of antibodies against follicle-stimulating hormone in female infertility: a study based on in vitro fertilization patients. Am J Reprod Immunol 57(3):193–200 (Epub 2007/02/14)
Fenichel P, Gobert B, Carre Y, Barbarino-Monnier P, Hieronimus S (1999) Polycystic ovary syndrome in autoimmune disease. Lancet 353(9171):2210 (Epub 1999/07/07)
Gleicher N, el-Roeiy A, Confino E, Friberg J (1989) Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 160(6):1376–1380 (discussion 80–5; epub 1989/06/01)
Putowski L, Darmochwal-Kolarz D, Rolinski J, Oleszczuk J, Jakowicki J (2004) The immunological profile of infertile women after repeated IVF failure (preliminary study). Eur J Obstet Gynecol Reprod Biol 112(2):192–196 (Epub 2004/01/30)
Bats AS, Barbarino PM, Bene MC, Faure GC, Forges T (2008) Local lymphocytic and epithelial activation in a case of autoimmune oophoritis. Fertil Steril 90(3):849 e5–849 e8 (epub 2007/12/07)
Shatavi SV, Llanes B, Luborsky JL (2006) Association of unexplained infertility with gonadotropin and ovarian antibodies. Am J Reprod Immunol 56(5–6):286–291 (epub 2006/11/02)
Hefler-Frischmuth K, Walch K, Huebl W, Baumuehlner K, Tempfer C, Hefler L (2010) Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril 93(7):2291–2294
Haller-Kikkatalo K, Salumets A, Uibo R (2012) Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone. Clin Dev Immunol 2012:762541 (epub 2011/10/19)
Weghofer A, Himaya E, Kushnir VA et al (2015) Some aspects of interactivity between endocrine and immune systems required for successful reproduction. Reprod Biol Endocrinol 13(1):29
Acknowledgements
We would like to thank all the participants and co-workers in Royan Institute for their assistance in this study.
Funding
No financial support has been granted.
Author information
Authors and Affiliations
Contributions
MA (M.D): designing the research, project development, manuscript writing/editing and approve for publication. EA (M.D, Ph.D.): design, revising manuscript and approve for publication. AA (M.Sc): project development, patient selection writing and revising manuscript and approve for publication. SV (M.Sc): data analysis and revising manuscript and approve for publication. RS-Y (DCLS): data collection, revising manuscript and approve for publication.
Corresponding author
Ethics declarations
Conflict of interest
Author Mahnaz Ashrafi declares that she has no conflict of interest. Author Arezoo Arabipoor declares that she has no conflict of interest. Author Elham Amirchaghmaghi declares that she has no conflict of interest. Author Smira Vesali declares that she has no conflict of interest. Author Reza Salman-Yazdi declares that she has no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards committee of Royan Institute and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethics approval code (EC/09/1060).
Informed consent
Informed written consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Ashrafi, M., Amirchaghmaghi, E., Arabipoor, A. et al. The effects of superovulation with gonadotropins on autoantibody levels in patients undergoing assisted reproductive cycles. Arch Gynecol Obstet 298, 183–189 (2018). https://doi.org/10.1007/s00404-018-4775-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-018-4775-8